Tom Hubbard leads NEHI’s projects on coverage and payment for innovative biopharmaceuticals, comparative effectiveness research policy, Real World Evidence, medication management and patient medication adherence. Mr. Hubbard leverages his policy and technology experience to examine ways the country’s health care system can be transformed, focusing on the promotion of medical innovation and the improvement of quality and efficiency in clinical care.
Mr. Hubbard came to NEHI after seven years at the Massachusetts Technology Collaborative (MTC), where he led industry-focused projects and supervised the annual publication of the MTC Index of the Massachusetts Innovation Economy. His work has included supervising the I-495 Technology Corridor Partnership, an industry-municipal collaboration on growth, and leading projects on broadband deployment, federal research funding advocacy, and nanotechnology.
Previously, Mr. Hubbard served as Executive Assistant for Economic Affairs to U.S. Senator John Kerry, as Deputy Director of Development for Massachusetts Governor Michael Dukakis, and as Director of Community Development and Planning for the City of Gardner, Massachusetts.
Mr. Hubbard graduated from Harvard College and holds a masters in public policy from Harvard’s Kennedy School of Government.
Valerie Fleishman provides the strategic and operational direction for NEHI. As Executive Director, she oversees the institute’s policy research, programs, operations, fundraising and communications. Under her leadership, NEHI's programs seek to improve chronic illness care, promote disease prevention and wellness, and speed the adoption of valuable innovations across the health care system. She has authored numerous reports, articles and briefs on a wide range of health policy issues.
Ms. Fleishman joined NEHI at its founding in 2002. She has over fifteen years’ experience in health care, health policy, technology and innovation. Prior to joining NEHI, Ms. Fleishman was a director in Health and Wellness at Scient Corporation, where she led strategic consulting engagements with leading biotechnology, medical device and pharmaceutical clients in areas such as telemedicine, disease management, health information technology, clinical trials, and sales and marketing strategies.
Previously, Ms. Fleishman was a manager in Arthur D. Little's Global Strategy Practice. She also worked in product management and brand marketing at Johnson & Johnson's McNeil Consumer Products.
Ms. Fleishman received her bachelor of arts, cum laude, from Harvard University and her master of business administration from the Harvard Business School. In 2008, she was honored as one of Boston’s "40 under 40" by the Boston Business Journal.
